Omnicell , Inc. (NASDAQ:OMCL), a leading provider of medication management solutions in the healthcare technology sector, has been navigating a complex market environment characterized by both ...

In the latest quarter, 4 analysts provided ratings for Omnicell OMCL, showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates the ...

Importantly, our data indicates that Omnicell's profit was reduced by US$9.9m, due to unusual items, over the last year. It's never great to see unusual items costing the company profits ...

Omnicell’s OMCL fourth-quarter 2024 performance was driven by its long-term development strategy, such as innovative solutions, expansion into new markets, strategic partnerships and procurement ...

Omnicell (OMCL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BeiGene (ONC – Research Report) and Omnicell (OMCL – Research Report). See what stocks are ...

FORT WORTH, Texas (AP) — FORT WORTH, Texas (AP) — Omnicell Inc. (OMCL) on Thursday reported fourth-quarter profit of $15.8 million. On a per-share basis, the Fort Worth, Texas-based company ...